Nieć Dawid, Kunicki Paweł K
Department of Clinical Biochemistry, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
Department of Clinical Biochemistry, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:63-70. doi: 10.1016/j.jchromb.2015.07.004. Epub 2015 Jul 29.
Measurements of plasma concentrations of free normetanephrine (NMN), metanephrine (MN) and methoxytyramine (MTY) constitute the most diagnostically accurate screening test for pheochromocytomas and paragangliomas. The aim of this article is to present the results from a validation of an analytical method utilizing high performance liquid chromatography with coulometric detection (HPLC-CD) for quantifying plasma free NMN, MN and MTY. Additionally, peak integration by height and area and the use of one calibration curve for all batches or individual calibration curve for each batch of samples was explored as to determine the optimal approach with regard to accuracy and precision.
The method was validated using charcoal stripped plasma spiked with solutions of NMN, MN, MTY and internal standard (4-hydroxy-3-methoxybenzylamine) with the exception of selectivity which was evaluated by analysis of real plasma samples. Calibration curve performance, accuracy, precision and recovery were determined following both peak-area and peak-height measurements and the obtained results were compared. The most accurate and precise method of calibration was evaluated by analyzing quality control samples at three concentration levels in 30 analytical runs.
The detector response was linear over the entire tested concentration range from 10 to 2000pg/mL with R(2)≥0.9988. The LLOQ was 10pg/mL for each analyte of interest. To improve accuracy for measurements at low concentrations, a weighted (1/amount) linear regression model was employed, which resulted in inaccuracies of -2.48 to 9.78% and 0.22 to 7.81% following peak-area and peak-height integration, respectively. The imprecisions ranged from 1.07 to 15.45% and from 0.70 to 11.65% for peak-area and peak-height measurements, respectively. The optimal approach to calibration was the one utilizing an individual calibration curve for each batch of samples and peak-height measurements. It was characterized by inaccuracies ranging from -3.39 to +3.27% and imprecisions from 2.17 to 13.57%.
The established HPLC-CD method enables accurate and precise measurements of plasma free NMN, MN and MTY with reasonable selectivity. Preparing calibration curve based on peak-height measurements for each batch of samples yields optimal accuracy and precision.
测量血浆中游离去甲肾上腺素(NMN)、肾上腺素(MN)和甲氧基酪胺(MTY)的浓度是嗜铬细胞瘤和副神经节瘤诊断最准确的筛查试验。本文旨在介绍一种利用高效液相色谱-库仑检测法(HPLC-CD)定量血浆游离NMN、MN和MTY的分析方法的验证结果。此外,还探讨了通过峰高和峰面积进行峰积分以及对所有批次使用一条校准曲线或对每批样品使用单独校准曲线,以确定在准确性和精密度方面的最佳方法。
该方法通过向经活性炭处理的血浆中加入NMN、MN、MTY和内标(4-羟基-3-甲氧基苄胺)溶液进行验证,但选择性通过分析实际血浆样品来评估。在进行峰面积和峰高测量后,确定校准曲线性能、准确性、精密度和回收率,并比较所得结果。通过在30次分析运行中分析三种浓度水平的质量控制样品,评估最准确和精密的校准方法。
在10至2000pg/mL的整个测试浓度范围内,检测器响应呈线性,R(2)≥0.9988。每种目标分析物的最低定量限(LLOQ)为10pg/mL。为提高低浓度测量的准确性,采用了加权(1/量)线性回归模型,峰面积积分和峰高积分后的误差分别为-2.48%至9.78%和0.22%至7.81%。峰面积测量和峰高测量的不精密度分别为1.07%至15.45%和0.70%至11.65%。校准的最佳方法是对每批样品使用单独的校准曲线并进行峰高测量。其特点是误差范围为-3.39%至+3.27%,不精密度为2.17%至13.57%。
所建立的HPLC-CD方法能够以合理的选择性准确、精密地测量血浆游离NMN、MN和MTY。基于每批样品的峰高测量制备校准曲线可获得最佳的准确性和精密度。